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IntegrinCell invasion and adhesion play an important role in cancer metastasis and are orchestrated by a complicated
network of transcription factors including p63. Here, we show that a member of the tripartite motif protein
family, TRIM29, is required for regulation of the p63-mediated pathway in cervical cancer cells. TRIM29 knock-
down alters the adhesion and invasion activities of cervical cancer cells. TRIM29 knockdown and overexpression
cause a signiﬁcant decrease and increase of TAp63α expression, respectively. TRIM29 knockdown alters the
expression pattern of integrins and increases ZEB1 expression. TRIM29 is required for suppression of an increase
in the adhesion activity of cells by TAp63α. These ﬁndings suggest that TRIM29 regulates the p63-mediated
pathway and the behavior of cervical cancer cells.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Invasion and migration are signiﬁcant hallmarks of metastatic can-
cer cells. Epithelial to mesenchymal transition (EMT) allows cancer
cells to acquire metastatic ability [1]. During the EMT process, interac-
tion of integrinswith the extracellularmatrix (ECM) exerts a prominent
role by regulating the function of matrix metalloproteinases (MMPs)
[1]. The degradation of ECMcomponents byMMPs contributes to cancer
metastasis by changing the tumor microenvironment [1]. These bio-
logical processes are orchestrated by a network of transcription factors
including SNAIL1/2, TWIST1/2 and ZEB1/2 [1]. In addition to these tran-
scription factors, one of the members of the p53 family, p63, is involved
in cancer metastasis by regulating the expression of integrins [2,3].
Uterine cervical cancer is one of the common health problems for
women worldwide [4]. Human papillomavirus (HPV) is a signiﬁcant
risk factor associated with invasive cervical cancer [5]. Among the vari-
ous HPV types, HPV-18 is strongly related to adenocarcinoma of the
uterine cervix, whereas HPV-16 is detected more frequently in squa-
mous cell carcinoma than in adenocarcinoma [6,7]. HPV infection en-
hances the invasion activity of cervical cancer cells by upregulation of
MMPs [8]. In cervical cancer cells, epidermal growth factor promotes
the transition of epithelial cells to mesenchymal cells, being dependent
on SNAIL1 and α5β1 integrin [9]. Interaction of α5β1 integrin with ﬁ-
bronectin contributes to the migration with up-regulation of MMP-9
in cervical cancer cells [10]. Although EMT-related genes contribute to
metastasis of cervical cancer, how cervical cancer cells gain invasive
ability remains to be elucidated.ma).TRIM29 has been identiﬁed as an ataxia telangiectasia group D-
complementing gene in a functional complementation study with an
AT cell line by transfection with a human cosmid library [11]. TRIM29
is a member of the tripartite motif (TRIM) protein family and is speciﬁ-
cally expressed in squamous cells [12,13]. There is increasing evidence
that TRIM29 enhances or suppresses cell invasion depending on cell
type. In breast cancer cells, TRIM29 suppresses invasiveness by down-
regulating the expression of TWIST1 [14]. TRIM29 promotes cell inva-
sion by regulating MMP-9 in lung cancer [15]. TRIM29 also regulates
the invasion of pancreatic cancer cells by inducing EMT [16]. Further-
more, it has been reported that overexpression of TRIM29 is associated
withmalignancy of various cancers including bladder, colorectal, gastric
lung and pancreatic cancers [12]. To date, it has been controversial
whether TRIM29 functions as an oncogene or tumor suppressor. Al-
though expression of TRIM29 is closely related to the characteristics
and malignancy of cancer, the relationship between TRIM29 and cervi-
cal cancers remains incompletely understood.
In this study, we identiﬁed TRIM29 as a regulator of the p63-
mediated pathway in cervical cancer cells. TRIM29 was required for
the suppression of ZEB1 and integrin β1 (ITGB1). Depletion of TRIM29
suppressed an elevation of the adhesion activity of cells by TAp63α.
We propose that TRIM29 regulates the p63-mediated pathway and
the behavior of cervical cancer cells.
2. Materials and methods
2.1. Plasmid
Full-length human TRIM29 (NM_012101.3) was ampliﬁed using
total RNA from HeLa cells. TAp63α-FLAG was a gift from David
Sidransky (Addgene plasmid # 27008).
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cDNAs encoding full-length TRIM29 and TAp63α were introduced
by retroviral transduction into a HeLa S3 cell line stably expressing the
mouse ectopic retrovirus receptor (mCAT-1) [17]. Retroviruses were
produced with Plat-E packaging cells [18].
2.3. Cell culture
HeLa, HeLa S3 and SiHa cell lineswere obtained fromAmerican Type
Culture Collection (Manassas, VA), which authenticates human cell
lines in their collection, and were cultured in DMEM (Sigma-Aldrich
Corp., St Louis, MO) supplemented with 10% fetal bovine serum (FBS)
under an atmosphere of 5% CO2 at 37 °C. Unless otherwise indicated,
cells were cultured in a 100-mm plastic dish (Corning 430167; Corning
Co., NY). For large-scale cultures, parental and FLAG-tagged TRIM29-
expressing HeLa S3 cells were cultured in Joklik's medium (Sigma) sup-
plemented with 5% calf serum (Invitrogen, Carlsbad, CA) using spinner
culture.
2.4. Antibodies
Mouse anti-FLAG M2 was purchased from Sigma (Sigma). Mouse
anti-TRIM29 (A-5: sc-166718), rabbit anti-p63 (H-137: sc-8343),
mouse anti-p53 (DO-1: sc-126) rabbit anti-Pol II (N-20: sc-899) and
mouse anti-actin (C-2: sc-8432) were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA.). Rabbit anti-Integrin β4 (4707) was pur-
chased from Cell Signaling Technology (Beverly, MA). Rabbit anti-
Integrin β1 (ab52971) was purchased from Abcam (Cambridge, UK).
Mouse anti-GAPDH (AM4300) was purchased from Ambion (Austin,
TX). Rabbit anti-MED12 was purchased from Bethyl Laboratories
(Bethyl Laboratories, Montbomery, TX).
2.5. siRNA transfections
HeLa S3, HeLa and SiHa cells in 10-cm dishes (~2 × 106 cells/dish)
were transfected with 25 nM siRNA ON-TARGETplus human TRIM29
siRNA SMART pool (Dharmacon, Pittsburgh, PA) or 25 nM siGENOME
NON-TARGETING siRNA Pool #2 (Dharmacon) using Lipofectamine
RNAiMAX (Invitrogen). After 48-h culture, cells were subjected to
each analysis.
2.6. Quantitative real-time PCR
Total RNA was extracted using ISOGEN II (Nippon Gene, Tokyo,
Japan). cDNA was prepared by using oligonucleotide (dT) and a
ReverTra-Plus kit (TOYOBO, Japan) for quantitative real-time PCR
(qRT-PCR). The threshold cycle (Ct) values were determined by qRT-
PCR using Express SYBRGreenER qPCR Supermix Universal (Invitrogen)
on an ABI Prism 7900HT Sequence Detection System (Applied Biosys-
tems, Foster City, CA). ΔCt was obtained by subtracting the Ct value of
the GAPDH gene from the Ct value of the respective gene. The relative
expression level of mRNA was determined by 2−ΔCt. All PCR primers
were as follows: TRIM29, 5′-AAAGGCTATCCCTCCCTCAT-3′ (forward)
and 5′-TAGAATGGCCGGTAGTGAGA-3′ (reverse); p63, 5′-GCAGCTTT
GCAAACC CATTA-3′ (forward) and 5′-GCTCGGAAGTCCTAGGTTTATT-3′
(reverse); TAp63, 5′-TGTATCCGCATGCAGGACT-3′ (forward) and 5′-
CTGTGTTATAGGGACTGGTGGAC-3′ (reverse); ΔNp63, 5′-GAAAACAA
TGCCCAGACTCAA-3′ (forward) and 5′-TGCGCGTGGTCTGTGTTA-3′
(reverse); p63α, 5′-ATTGATGCTGTGCGATTCACC-3′ (forward) and 5′-
TGTTGCTTATTGCGGCGAG-3′ (reverse); p63β, 5′-AACGCCCTCACTCCTA
CAAC-3′ (forward) and 5′-GACTTGCCAGATCCTGACAATG-3′ (reverse);
p63γ, 5′-GCAGCACCAGCACTTACTTCA-3′ (forward) and 5′-TGTTTTGG
AGTTTCTCTCCGG-3′ (reverse); SNAIL2, 5′-TTTCTGGGCTGGCCAAACAT
AAGC-3′ (forward) and 5′-ACACAAGGTAATGTGTGGGTCCGA-3′ (re-
verse); ZEB1, 5′-CAGGAAAGGAAGGGCAAGAA-3′ (forward) and 5′-TCTGCATCTGACTCGCATTC-3′ (reverse); p53, 5′-TTTCGACATAGTGTGG
TGGTG-3′ (forward) and 5′-GCCCATGCAGGAACTGTTA-3′ (reverse);
ITGB1, 5′-CCTGAAAGTCCCAAGTGTCAT-3′ (forward) and 5′-ACCAACAC
GCCCTTCATT-3′ (reverse); ITGB4, 5′-GAGCTGCATCGGCTCAA-3′ (for-
ward) and 5′-AACACGTAGGAGTGGTTGG-3′ (reverse); ITGA3, 5′-AAAC
TGTGGAGGATGTAGGAAG-3′ (forward) and 5′-CACTCCAGACCTAGGA
CCA-3′ (reverse); ITGA5, 5′-GGGACCTCAGATCCTGAAATG-3′ (forward)
and 5′-CTGCAGACTTTGGCTCTCTT-3′ (reverse); ITGA6, 5′-AGACTCTT
AACTGTAGCGTGAAC-3′ (forward) and 5′-ATAAGAGACGCCTTGCTGTC-
3′ (reverse); FN1, 5′-AGGAATATCTCGGTGCCATTT-3′ (forward) and 5′-
CTTCGGGACTGGGTTCAC-3′ (reverse); VIM, 5′-ATCCAAGTTTGCTGAC
CTCTC-3′ (forward) and 5′-CTCAGTGGACTCCTGCTTTG-3′ (reverse);
SOX2, 5′-TACAGCATGATGCAGGACCA-3′ (forward) and 5′-TACTGCAG
GGCGCTCAC-3′ (reverse); RB1, 5′-GGATGGAGTATTGGGAGGTTAT-3′
(forward) and 5′-AGTGAACGACATCTCATCTAGG-3′ (reverse); FOXM1,
5′-AAGATGAGTTCTGATGGACTGG-3′ (forward) and 5′-AAGGCTCCTC
AACCTTAACC-3′ (reverse); E2F1, 5′-GGAGAAGTCACGCTATGAGAC-3′
(forward) and 5′-GTCGACGACACCGTCAG-3′ (reverse); E2F2, 5′-GTCC
CTGAGTTCCCAACC-3′ (forward) and 5′-GAAGTGTCATACCGAGTCTTCT-
3′ (reverse); E2F3, 5′-AGGCTGGAGCTAGGAGAAA-3′ (forward) and 5′-
CGTAGTGCAGCTCTTCCTTT-3′ (reverse); E2F4, 5′-CCGGGAGATTGCTG
ACAAA-3′ (forward) and 5′-CCTTGTGCTGGTCTAGTTCTT-3′ (reverse);
E2F5, 5′-ACCAATGTCTTAGAGGGAATTGA-3′ (forward) and 5′-TTTAGT
ATTACAGCCAGCACCT-3′ (reverse); E2F6, 5′-TCCAAGAACCATATTAGA
TGGATAGG-3′ (forward) and 5′-ATTAACTCATCCAAAGCATCTTCC-3′
(reverse); HOXB5, 5′-TCCGCAAATATTCCCCTGGA-3′ (forward) and 5′-
CGGGTCAGGTAGCGGTTGAA-3′ (reverse); HOXB7, 5′-GACTTGGCGGCG
GAGAGTAA-3′ (forward) and 5′-CAGGGTCTGGTAGCGGGTGT-3′ (re-
verse); HOXB9, 5′-CCACTGGCTGCTGGACTGTT-3′ (forward) and 5′-
TATGACTGGGCCAGGTTCTTTG-3′ (reverse); BRCA1, 5′-GCATGCTGAA
ACTTCTCAACC-3′ (forward) and 5′-CGTACTTTCTTGTAGGCTCCTT-3′
(reverse); GAPDH, 5′-GTCAACGGATTTGGTCGTATTG-3′ (forward) and
5′-TGTAGTTGAGGTCAATGAAGGG-3′ (reverse).
2.7. Cell adhesion assay
Cell adhesion assay to ﬁbronectin, collagen I, collagen IV, laminin I
and vimentin was performed using a CytoSelect 48-well cell adhesion
assay extracellular matrix (ECM) array (Cell Biolabs Inc., San Diego,
CA) according to the manufacturer's instructions. Cells were incubated
on the ECM array for 1 h under an atmosphere of 5% CO2 at 37 °C in a
serum-free medium. Each well was gently washed to remove non-
adherent cells. Adherent cells were stained by Cell Stain Solution. The
stains were extracted by Extract Solution and quantiﬁed by measuring
absorbance at 595 nm.
2.8. Cell invasion assay
Cell invasion assay was performed using a CytoSelect 24-well cell
invasion assay kit (Cell Biolabs Inc.) according to themanufacturer's in-
structions. Cellswere incubated on the upper chamber on a polycarbon-
atemembrane coatedwith basementmembranematrix in a serum-free
medium. Cells were incubated for 1 h under an atmosphere of 5% CO2 at
37 °C. Non-invasive cells were gently removed from the interior of the
chamber. Cells that had invaded to the bottom of the membrane were
stained by Cell Stain Solution. The stainswere extracted by Extract Solu-
tion and quantiﬁed by measuring absorbance at 595 nm.
2.9. Immunostaining
Cells were cultured on a cover glass in DMEM supplemented with
10% FBS under an atmosphere of 5% CO2 at 37 °C. The cells were ﬁxed
by 4% paraformaldehyde in PBS for 15 min at room temperature,
washed with PBS three times, and then incubated with blocking buffer
(5% normal goat serum and 0.1% Triton X-100 in PBS) for 1 h. After
blocking, the cells were incubated with primary antibodies in blocking
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labeled anti-mouse IgG or goat Alexa Fluor 555-labeled anti-rabbit IgG
antibody (Invitrogen) for 1 h at room temperature. DNA was counter-
stained with 0.4 μg/ml DAPI in PBS for 30 min at room temperature.
Confocal images were taken using an upright microscope (FV1000,
Olympus, Tokyo, Japan).
2.10. Analysis of focal adhesion area
Cells were transfected with siControl or siTRIM29 and incubated on
ﬁbronectin-coated coverslips in serum-free medium. After 48 h, cells
were ﬁxed and stained with anti-actin and anti-ITGB1 antibodies. DNA
was counterstainedwithDAPI (0.4 μg/ml). Cell adhesion areawas calcu-
lated as the ratio of ITGB1-stained area to DAPI-stained area. ITGB1- and
DAPI-stained areas were quantiﬁed using NIH ImageJ software (n =
20).
2.11. FLAG immunoprecipitation
Nuclear extracts of HeLa S3 cells expressing FLAG-tagged TRIM29
were prepared according to Dignam's method [19]. Anti-FLAG afﬁnity
puriﬁcations were performed as described previously [20].0
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Fig. 1. TRIM29 regulates cell adhesion and invasion. (A,B,C) Effect of TRIM29 knockdown on ce
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tomeasure absorbance at 595 nm. Standard deviations of each resultwere calculated from three
bars show s.d. (D) Effect of TRIM29 knockdown on invasion to the basement membrane mat
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HeLa S3, HeLa and SiHa cells were transfected with siCTRL and siTRIM29 and then incubated f3. Results
3.1. TRIM29 regulates cell adhesion and invasion
To reveal the function of TRIM29 in cervical cancer cells, we knocked
down TRIM29 in HeLa S3 (HPV-18-positive), HeLa (HPV-18-positive)
and SiHa (HPV-16-positive) cells by siRNA transfection and then per-
formed an in vitro cell adhesion assay using plates coatedwith ﬁbronec-
tin, ﬁbrinogen, collagen I, collagen IV or laminin I. TRIM29 knockdown
in HeLa S3 cells increased the adhesion activity of cells to ﬁbronectin
(4.4-fold), ﬁbrinogen (2.6-fold), collagen IV (1.7-fold) and collagen I
(1.5-fold) (Fig. 1A), and TRIM29 knockdown in HeLa cells increased in
adhesion activity to ﬁbronectin (2.2-fold), collagen IV (2.7-fold) and
collagen I (3.8-fold) (Fig. 1B). TRIM29 depletion in SiHa cells did not
have a signiﬁcant effect on adhesion activity (Fig. 1C). It has been re-
ported that TRIM29 regulates invasion of lung and breast cancer cells
[14–16]. To examine whether TRIM29 regulates cell invasion, we per-
formed an in vitro cell invasion assay using polycarbonate membranes
coated with basement membrane matrix. TRIM29 knockdown reduced
the invasion activity of HeLa S3 and SiHa cells (Fig. 1D). In addition, we
conﬁrmed a reciprocal relationship between cell morphology and
TRIM29 knockdown in each cell line. Knockdown of TRIM29 caused a
signiﬁcant change in morphology of HeLa S3 cells but not morphologyC
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ulates adhesion and invasion depending on the type of cervical cancer
cells.
3.2. Effect of TRIM29 knockdown on focal adhesion
ITGB1 plays a major role in binding to ECM components and con-
tributes to the formation of focal adhesion [21]. To examine the effect
of TRIM29 depletion on focal adhesion area of cells, we depleted HeLa
S3, HeLa and SiHa cells of TRIM29 by siRNA transfection and then
incubated the TRIM29-depleted cells on ﬁbronectin-coated coverslips
in serum-free medium for 24 h (Fig. 2A and B). We deﬁned the ratio
of ITGB1-stained area to DAPI-stained area as focal adhesion area.
TRIM29 knockdown increased the focal adhesion area in HeLa S3 and
HeLa cells but not in SiHa cells (Fig. 2C). These ﬁndings suggest that
TRIM29 regulates focal adhesion depending on the type of cells.A
B
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Student's t test (*, P b 0.05). Error bars show s.d.3.3. TRIM29 transcriptionally regulates ZEB1 and TAp63α isoform
To reveal the relationship between TRIM29 and the behavior of
cervical cancer cells, we examined the effects of TRIM29 knockdown
on relative mRNA levels of p63 and EMT-related transcription factors.
We also examined E2F and HOXB transcription factors, which are asso-
ciated with cancer progression [22,23]. We suppressed TRIM29 in HeLa
S3, HeLa and SiHa cells by siRNA transfection and analyzed the expres-
sion of indicated genes by qRT-PCR. Among the indicated genes, TRIM29
knockdown decreased the mRNA level of p63, whereas the mRNA level
of ZEB1 was elevated in TRIM29-depleted cells (Fig. 3A–C). We also
found that p53 and SNAIL2 were signiﬁcantly upregulated depending
on the cell type (Fig. 3A–C).
The p63 gene has two distinct promoters that produce two sub-
classes of p63: transactivating p63 (TAp63) and N-terminal truncat-
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p63 are regulated by TRIM29, we performed qRT-PCR using previ-
ously reported primers that are speciﬁc for the isoforms of p63
(TAp63, ΔNp63, p63α, p63β and p63γ) [3]. While TAp63 isoforms
were highly expressed, mRNA level of the ΔNp63 isoform was
much lower than that of the TAp63 isoform (Fig. 3D–F). In addition,
mRNA level of the p63α isoform was much higher than the levels of
p63β and p63γ isoforms (Fig. 3D–F). TRIM29 knockdown in each
cell line suppressed the expression of TAp63, p63α and p63γ iso-
forms (Fig. 3D–F). Taken together, these ﬁndings indicate that
TRIM29 is a transcriptional regulator of TAp63α and ZEB1 in cervi-
cal cancer cells.3.4. TRIM29 regulates the expression of cell adhesion genes
p63 regulates the expression of cell adhesion genes including β1-
integrin (ITGB1), β4-integrin (ITGB4), α3-integrin (ITGA3), α5-
integrin (ITGA5), α6-integrin (ITGA6), ﬁbronectin (FN1) and vimentin
(VIM) [2]. To clarify the relationship between TRIM29 and p63, we ana-
lyzed the effect of TRIM29 depletion on the expression of these genes.
Knockdown of TRIM29 in HeLa S3 and HeLa cells had similar effects
on the expression of ITGB1, ITGB4, ITGA5 and FN1 (Fig. 4A and B).
TRIM29 knockdown in SiHa cells caused an increase in the expression
of ITGB4 and a decrease in the expression of FN1 (Fig. 4C). In addition,
loss of TRIM29 in each cell line increased the mRNA level of VIM,
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Quantitative RT-PCR analysis was performed to measure mRNA levels of integrins, FN1
and VIM in TRIM29-knockdown HeLa S3 (A), HeLa (B) and SiHa (C) cells. Using the
same procedure as that described in the legend of Fig. 3, mRNA levels of ITGB1, ITGB4,
ITGA5, ITGA6, FN1 and VIM were analyzed by quantitative RT-PCR. Standard deviations
of each result were calculated from three independent experiments. P values were
determined by Student's t test (*, P b 0.05). Error bars show s.d.
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that TRIM29 regulates the expression of cell adhesion molecules in cer-
vical cancer cells. However, the transcriptional regulation of cell adhe-
sion genes by TRIM29 is dependent on the type of cells.
3.5. TRIM29 interacts with TAp63α in cervical cancer cells
To conﬁrm that TRIM29 regulates the p63-mediated pathway, we
examined the effect of TRIM29 knockdown on the protein levels of
p63, ZEB1, ITGB1 and ITGB4 by immunoblot analysis. HeLa S3, HeLa
and SiHa cells were transfected with TRIM29 siRNA, and the whole
cell lysates were subjected to SDS-PAGE followed by immunoblotting
with the indicated antibodies. TRIM29 knockdown led to a slight
decrease in the protein level of TAp63α in HeLa S3 cells but not in
HeLa and SiHa cells (Fig. 5A). TRIM29 knockdown caused increased ex-
pression of ZEB1 in HeLa S3, HeLa and SiHa cells (Fig. 5A). While ITGB1was increased in HeLa S3 and HeLa cells by TRIM29 knockdown, ITGB4
was decreased in HeLa cells and was slightly increased in SiHa cells by
TRIM29 depletion (Fig. 5A).
Nuclear localization of p63 is required for its function as a trans-
cription factor. To examine whether TRIM29 regulates the subcellular
localization of p63, we incubated TRIM29-depleted cells on coverslips
and then analyzed the subcellular localization of p63 by immuno-
ﬂuorescence staining. TRIM29 depletion did not alter the subcellular
localization of p63 in each cell line (Fig. 5B).
Depletion of TRIM29 elevated the level of ZEB1 protein in each cell
line (Fig. 5A). These ﬁndings raised the possibility that TRIM29 sup-
presses the expression of ZEB1 by interacting with TAp63α in cervical
cancer cells. To determine whether TRIM29 physically interacts with
TAp63α, we generated HeLa S3 cells stably expressing N-terminal
FLAG-tagged TRIM29, prepared nuclear extracts from the cells, and pu-
riﬁed FLAG-tagged TRIM29-binding proteins by anti-FLAG immuno-
precipitation. As expected, we found that TRIM29 interacted with
TAp63α (Fig. 5C). A recent study showed that knockdown of MED12,
which is a key subunit of the Mediator complex, upregulates the ex-
pression of EMT-related genes [25]. To further determine the role of
TRIM29 in the transcription of EMT-related genes, we conﬁrmed
whether TRIM29 interacts with MED12 and RNA polymerase II (Pol
II). Western blot analysis showed that TRIM29 binds to Pol II and
MED12 (Fig. 5C). These ﬁndings suggest that TRIM29 regulates ZEB1
suppression and integrin expression through TAp63α, Pol II and
MED12.
3.6. Forced expression of TRIM29 upregulates ITGB4
To address the reciprocal relationship between TRIM29 and TAp63α,
we analyzed the effect of TRIM29 overexpression on the expression of
p63 isoforms and integrins by qRT-PCR. We conﬁrmed that the mRNA
level of TRIM29 was greatly increased in FLAG-TRIM29-expressing
HeLa S3 cells (Fig. 6A). TRIM29 overexpression caused an increase in
the expression levels of TAp63, p63α, p63β and p63γ but not in that
ofΔNp63 (Fig. 6B). Overexpression of TRIM29 also resulted in increases
in ITGB4, ITGA3 and ITGA6 expression levels (Fig. 6C). Although cells ex-
pressing FLAG-TRIM29 showed an increase in ITGB1 expression,
TRIM29 overexpression had less of an impact on ITGB1 expression
than did TRIM29 knockdown (Figs. 4A and 6C). We also conﬁrmed the
effect of TRIM29 overexpression on protein levels of TAp63α, ITGB1
and ITGB4 by Western blotting. TRIM29 overexpression resulted in an
increased level of ITGB4 but not in increased levels of TAp63α and
ITGB1 (Fig. 6D).
To conﬁrm the effect of TRIM29 overexpression on cell invasion and
adhesion, we performed in vitro cell invasion and adhesion assays.
TRIM29 overexpression caused a 1.9-fold increase in the invasion ac-
ivity of HeLa S3 cells (Fig. 6E). Although TRIM29 overexpression
decreased the adhesion activity of cells to collagen IV, there was no sig-
niﬁcant difference in the adhesion activity of cells to other ECM compo-
nents (Fig. 6F). HeLa S3 cells expressing FLAG-TRIM29 also exhibited a
marked change with tight cobblestone-like structures in cell morpholo-
gy (Fig. 6G). These ﬁndings suggest that TRIM29 overexpression en-
hances cell invasion and cell–cell interactions in HeLa S3 cells.
3.7. TRIM29 is required for regulation of the p63-mediated pathway
To clarify the functional relationship between TRIM29 and TAp63α,
we generated HeLa S3 cells stably expressing FLAG-tagged TAp63α and
knocked down TRIM29 in the cells by siRNA transfection.We conﬁrmed
that FLAG-tagged TAp63α was expressed at a higher level than that of
endogenous TAp63α (Fig. 7A and B). Although TRIM29 depletion in-
creased the levels of ZEB1 and ITGB1, overexpression of TAp63α did
not suppress the elevation of ZEB1 and ITGB1 levels (Fig. 7A and B).
These ﬁndings suggest that TRIM29 regulates the expression of ZEB1
and ITGB1 independently of TAp63α.
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HeLa S3 cells to ECM components (Fig. 1A). To examine the effect of
TAp63α overexpression on cell adhesion to the ECM, we performed
in vitro cell adhesion assays. In the presence of endogenous TRIM29,
overexpression of TAp63α had no effect on the adhesion activity of
cells to ECM components (Fig. 7C). Conversely, overexpression of
TAp63α increased the adhesion activity of TRIM29-depleted cells to ﬁ-
bronectin, collagen I and collagen IV (Fig. 7C). These ﬁndings suggest
that TRIM29 negatively regulates an increase in the adhesion activity
of HeLa S3 cells by TAp63α.
4. Discussion
In this study, we showed that TRIM29 is an important regulator of
the p63-mediated pathway in cervical cancer cells (Fig. 7D). p63 has a
critical role in cell adhesion through the regulation of integrin expres-
sion [2], and it inhibits the expression of ZEB1 in pancreatic and bladder
cancer cells [30,31]. TRIM29 knockdown increased ZEB1 and ITGB1
levels in cervical cancer cells. However, TAp63α overexpression did
not suppress the elevation of ZEB1 and ITGB1 levels in TRIM29-depleted cells, indicating that TRIM29 suppresses the expression of
ZEB1 and ITGB1 independently of TAp63α. We also identiﬁed MED12,
which is a key component of the Mediator complex [28,29], as a
binding partner of TRIM29. Given that loss of MED12 upregulates
EMT-related genes in lung cancer cells [25], our observations raise
the possibility that TRIM29 suppresses the expression of ZEB1 and
ITGB1 through MED12. Furthermore, knockdown and overexpres-
sion experiments showed that TRIM29 regulates the mRNA level of
TAp63α, suggesting that mRNA levels of TAp63α are regulated
through the interaction with TRIM29 and MED12. This is important
for understanding the detailed mechanism by which TRIM29 regu-
lates TAp63α via MED12.
In cervical cancer cells, depletion and overexpression of TRIM29 af-
fected the expression pattern of ITGB1 and ITGB4 and adhesion activity
to the ECM. ITGB1 is essential for interaction of basal epithelial cellswith
the ECM [32]. ITGB4 expression disrupts adhesive activity and enhances
invasive activity of epithelial cells [33]. However, loss of TRIM29 exerted
different effects on integrin expression and cell adhesion in HPV-18-
positive cells (HeLa and HeLa S3) and HPV-16-positive cells (SiHa). In
cervical cancer cells, HPV genomes are integrated into the host genome,
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2303Y. Masuda et al. / Biochimica et Biophysica Acta 1853 (2015) 2296–2305followed by chromosomal rearrangement and instability [34]. The inte-
gration of HPV genomes into the host genome disrupts several genes
[35,36]. Previous studies showed that HPV-18 and HPV-16 genomes
are integrated into chromosomes 8 and 13, respectively [35,36]. Thus,
the difference in HPV integration sites may cause an alteration in the
expression of cell adhesion genes. Further detailed studies on themech-
anism by which TRIM29 regulates the expression of EMT-related genesin HPV-18 and HPV-16-positive cells might be useful for understanding
the phenotypes of cervical cancers.
In this study, we found that TRIM29 enhances invasion of cervical
cancer cells. While TRIM29 inhibits invasion of breast cancer cells [14],
it enhances invasion of pancreatic and lung cancer cells [15,16]. Degra-
dation of the ECM by MMPs has an important role in cell invasion and
metastasis [37]. It has been reported that HPV infection increases the
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2304 Y. Masuda et al. / Biochimica et Biophysica Acta 1853 (2015) 2296–2305expression of various MMPs in cervical cancer cells [8]. Thus, the in-
vasive activity of cervical cancer cells may be regulated by the inter-
play between the function of TRIM29 and the effect of HPV infection.
Further studies will be required for determination of the mechanism
by which TRIM29 regulates the invasive activity of cervical cancer
cells.
We found that TAp63α is maintained at a constant protein level in-
dependently of the mRNA level of TAp63α. There are several reports
that ubiquitination of TAp63α by E3 ubiquitin ligase plays an important
role in its stability. Ectopically expressed TAp63α is ubiquitinated and
degraded in an Itch-dependent manner [26]. In contrast, it has been re-
ported that βTrCP1 ubiquitinates and stabilizes TAp63α [27]. These
ﬁndings suggest that TAp63α is maintained at a constant level in a
ubiquitination-dependent manner speciﬁc for cervical cancer cells.
Our results demonstrate that TRIM29 regulates the p63-mediated
pathway and the behavior of cervical cancer cells. Further studies on
the mechanism by which TRIM29 regulates the characteristics ofcervical cancer cells may contribute to the establishment of new thera-
pies for cervical cancers.
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